Celldex Therapeutics, Inc (CLDX)
NASDAQ · Manufacturing · In vitro & in vivo diagnostic substances
$31.10−$0.3800 (−1.21%) on the dayAs of the close; data may be delayed.
CLDX price, last 12 months
Key stats
- Previous close
- $31.48
- Open
- $31.48
- Day range
- $30.65 – $31.71
- 52-week range
- $22.10 – $45.14
- Volume
- 2M
- Avg volume (20 days)
- 1.7M
- Market cap
- $2.4B
Performance
1W−18.7%
1M−23.3%
3M−11.8%
6M−2.1%
YTD+14.5%
1Y+21.5%
vs S&P 500, 1Y+4.7 pts
Technicals and fundamentals
About Celldex Therapeutics, Inc
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
- Sector
- Manufacturing
- Industry
- In vitro & in vivo diagnostic substances
- Listed on
- NASDAQ
- Market cap
- $2.4B